| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Chimpanzee,Dog,Horse,Human,Macaque,Mouse,Rat |
| Host species | Rabbit |
| Applications | WB-Ti,IHC-P |
| Brand: | Abnova |
| Reference: | PAB16535 |
| Product name: | TICAM2 polyclonal antibody |
| Product description: | Rabbit polyclonal antibody raised against synthetic peptide of TICAM2. |
| Gene id: | 353376 |
| Gene name: | TICAM2 |
| Gene alias: | MGC129876|MGC129877|TICAM-2|TIRAP3|TIRP|TRAM |
| Gene description: | toll-like receptor adaptor molecule 2 |
| Immunogen: | A synthetic peptide corresponding to amino acids 87-103 of human TICAM2. |
| Immunogen sequence/protein sequence: | EDDTDEALRVQNLLQDD |
| Protein accession: | AAO74498 |
| Form: | Liquid |
| Recommend dilutions: | Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (5 ug/mL) Western Blot (0.5-2 ug/mL) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In PBS (0.05% BSA, 0.05% sodium azide) |
| Storage instruction: | Store at 4°C. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Rabbit |
| Antigen species / target species: | Human |
| Specificity: | The amino acid sequence used as immunogen is 100% homologous in human, chimpanzee and rhesus monkey, 88% homologous in dog, mouse and rat and 82% homologous in horse. |
| Reactivity: | Chimpanzee,Dog,Horse,Human,Macaque,Mouse,Rat |
| Application image: | ![]() |
| Application image note: | Immunohistochemical analysis of TICAM2 in formalin-fixed, paraffin-embedded human brain tissue using an isotype control (top left) and TICAM2 polyclonal antibody (Cat # PAB16535) (bottom left, right) at 5 ug/mL . |
| Applications: | WB-Ti,IHC-P |
| Shipping condition: | Dry Ice |
| Publications: | LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF.Fitzgerald KA, Rowe DC, Barnes BJ, Caffrey DR, Visintin A, Latz E, Monks B, Pitha PM, Golenbock DT. J Exp Med. 2003 Oct 6;198(7):1043-55. Epub 2003 Sep 29. |